Daniel Ho:

About

Daniel E. Ho is the William Benjamin Scott and Luna M. Scott Professor of Law, Professor of Political Science, and Professor of Computer Science (by courtesy) at Stanford University. He is also a Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence and the Stanford Institute for Economic Policy Research. Additionally, he serves as a Senior Fellow at the Stanford Institute for Economic Policy Research and is the Director of the Regulation, Evaluation, and Governance Lab (RegLab). Ho's professional roles include serving on the National Artificial Intelligence Advisory Commission (NAIAC), advising the White House on artificial intelligence, acting as a Senior Advisor on Responsible AI at the U.S. Department of Labor, and being a Public Member of the Administrative Conference of the United States (ACUS). He holds a J.D. from Yale Law School and a Ph.D. from Harvard University, and he clerked for Judge Stephen F. Williams on the U.S. Court of Appeals, District of Columbia Circuit.

Research topics

• Medicine
• Internal medicine
• Immunology
• Pathology
• Biology
• Gastroenterology
• Microbiology
• Intensive care medicine
• Dermatology
• Virology

Selected publications

• Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients

  Viruses · 2023 · 77 citations

  Senior authorCorresponding

  Herpes simplex virus (HSV) and varicella zoster virus (VZV) are alpha herpesviruses that establish life-long latent infection in neuronal ganglia after primary infection. Periodic reactivation of these viruses results in recurrent infections that can have significant impact on patients' quality of life. HSV commonly causes oral and genital mucocutaneous infections whereas VZV is responsible for varicella/chickenpox and herpes zoster/shingles, but cancer patients are at particularly higher risk o…

  PublisherOA PDFDOI

• Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal Polymerase Chain Reaction Panel for Noninvasive Diagnosis of Fungal Infection

  Clinical Infectious Diseases · 2021 · 44 citations

  BACKGROUND: Invasive fungal infection (IFI) is a growing cause of morbidity and mortality in oncology and transplant patients. Diagnosis of IFI is often delayed due to need for invasive biopsy and low sensitivity of conventional diagnostic methods. Fungal cell-free DNA (cfDNA) detection in plasma is a novel testing modality for the noninvasive diagnosis of IFI. METHODS: A novel bioinformatic pipeline was created to interrogate fungal genomes and identify multicopy sequences for cfDNA polymerase…

  PublisherDOI

• Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis

  Journal of Clinical Microbiology · 2024-04-11 · 22 citations

  articleOpen access

  ABSTRACT Aspergillus species and Mucorales agents are the primary etiologies of invasive fungal disease (IFD). Biomarkers that predict outcomes are needed to improve care. Patients diagnosed with invasive aspergillosis and mucormycosis using plasma cell-free DNA (cfDNA) PCR were retested weekly for 4 weeks. The primary outcome included all-cause mortality at 6 weeks and 6 months based on baseline cycle threshold (CT) values and results of follow-up cfDNA PCR testing. Forty-five patients with Asp…

  PublisherOA PDFDOI

• Influence of immunosuppression on seroconversion against SARS‐CoV‐2 in two kidney transplant recipients

  Transplant Infectious Disease · 2020 · 19 citations

  Solid organ transplant recipients are at risk for infectious complications due to chronic immunosuppression. The outbreak of coronavirus disease 2019 (COVID-19) in the United States has raised growing concerns for the transplant patient population. We seek to add to the current limited literature on COVID-19 in transplant recipients by describing the clinical course of two kidney transplant recipients with SARS-CoV-2 infection monitored by both RT-PCR and serology. Through careful adjustment of…

  DOI

• Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease

  Clinical Infectious Diseases · 2025-01-17 · 16 citations

  article

  BACKGROUND: Mold plasma cell-free DNA (cfDNA) polymerase chain reaction (PCR) is a promising noninvasive diagnostic modality for early diagnosis of invasive mold disease (IMD) in immunocompromised patients. Although mold cfDNA PCR has been shown to be highly accurate, the value of invasive procedures to collect specimens for conventional fungal diagnostics following plasma cfDNA testing remains unclear. METHODS: This retrospective single-center cohort study included patients with mold plasma cfD…

  PublisherDOI

Frequent coauthors

• Robert M. Sapolsky

  Stanford University

  56 shared

• Sheri Fink

  34 shared

• Gary K. Steinberg

  Stanford Medicine

  32 shared

• Midori A. Yenari

  University of California, San Francisco

  32 shared

• Thomas Ringer

  Jena University Hospital

  26 shared

• Zhijian Zhang

  Huaqiao University

  26 shared

• Matthew S Lawrence

  Virscio (United States)

  15 shared

• Niaz Banaei

  Stanford University

  14 shared

Awards & honors

• Faculty Fellow at the Center for Advanced Study in the Behav…
• Director of the Regulation, Evaluation, and Governance Lab (…
• Member of the National Artificial Intelligence Advisory Comm…
• Senior Advisor on Responsible AI at the U.S. Department of L…
• Public Member of the Administrative Conference of the United…

Similar researchers at Stanford University

• Jon Krosnick:h-95
• Barry R. Weingast:h-79
• Shanto Iyengar:h-70